COVID-19 and the Endocrine System: A Comprehensive Review on the Theme.
Addison disease
COVID-19
Cushing syndrome
SARS-CoV-2
adrenal gland
hypercalcemia
osteoporosis
parathyroid
pituitary
review
thyroid
vitamin D
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
29 Jun 2021
29 Jun 2021
Historique:
received:
11
04
2021
revised:
31
05
2021
accepted:
23
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
The review aimed to summarize advances in the topic of endocrine diseases and coronavirus disease 2019 (COVID-19). Scientific and institutional websites and databases were searched and data were collected and organized, when plausible, to angle the discussion toward the following clinical issues. (1) Are patients with COVID-19 at higher risk of developing acute or late-onset endocrine diseases or dysfunction? (2) May the underlying endocrine diseases or dysfunctions be considered risk factors for poor prognosis once the infection has occurred? (3) Are there defined strategies to manage endocrine diseases despite pandemic-related constraints? Herein, the authors considered only relevant and more frequently observed endocrine diseases and disorders related to the hypothalamic-pituitary region, thyroid and parathyroid glands, calcium-phosphorus homeostasis and osteoporosis, adrenal glands, and gonads. Main. Data highlight the basis of some pathophysiological mechanisms and anatomical alterations of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-induced endocrine dysfunctions. Some conditions, such as adrenal insufficiency and cortisol excess, may be risk factors of worse clinical progression once the infection has occurred. These at-risk populations may require adequate education to avoid the SARS-CoV-2 infection and adequately manage medical therapy during the pandemic, even in emergencies. Endocrine disease management underwent a palpable restraint, especially procedures requiring obligate access to healthcare facilities for diagnostic and therapeutic purposes. Strategies of clinical triage to prioritize medical consultations, laboratory, instrumental evaluations, and digital telehealth solutions should be implemented to better deal with this probably long-term situation.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
The review aimed to summarize advances in the topic of endocrine diseases and coronavirus disease 2019 (COVID-19).
METHODS
METHODS
Scientific and institutional websites and databases were searched and data were collected and organized, when plausible, to angle the discussion toward the following clinical issues. (1) Are patients with COVID-19 at higher risk of developing acute or late-onset endocrine diseases or dysfunction? (2) May the underlying endocrine diseases or dysfunctions be considered risk factors for poor prognosis once the infection has occurred? (3) Are there defined strategies to manage endocrine diseases despite pandemic-related constraints? Herein, the authors considered only relevant and more frequently observed endocrine diseases and disorders related to the hypothalamic-pituitary region, thyroid and parathyroid glands, calcium-phosphorus homeostasis and osteoporosis, adrenal glands, and gonads. Main. Data highlight the basis of some pathophysiological mechanisms and anatomical alterations of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-induced endocrine dysfunctions. Some conditions, such as adrenal insufficiency and cortisol excess, may be risk factors of worse clinical progression once the infection has occurred. These at-risk populations may require adequate education to avoid the SARS-CoV-2 infection and adequately manage medical therapy during the pandemic, even in emergencies. Endocrine disease management underwent a palpable restraint, especially procedures requiring obligate access to healthcare facilities for diagnostic and therapeutic purposes. Strategies of clinical triage to prioritize medical consultations, laboratory, instrumental evaluations, and digital telehealth solutions should be implemented to better deal with this probably long-term situation.
Identifiants
pubmed: 34209964
pii: jcm10132920
doi: 10.3390/jcm10132920
pmc: PMC8269331
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Obes Res Clin Pract. 2020 Sep - Oct;14(5):398-403
pubmed: 32736969
Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93
pubmed: 24841273
J Thromb Haemost. 2020 Jun;18(6):1516-1517
pubmed: 32294289
Immun Ageing. 2021 Jan 4;18(1):1
pubmed: 33390183
J Clin Endocrinol Metab. 2015 Jun;100(6):2171-80
pubmed: 25844620
Int J Mol Sci. 2018 Mar 15;19(3):
pubmed: 29543707
BMJ Case Rep. 2021 Jan 18;14(1):
pubmed: 33462013
Lancet Respir Med. 2020 Jul;8(7):687-695
pubmed: 32386571
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Endocr Connect. 2018 Jul;7(7):G8-G11
pubmed: 29930026
J Endocrinol Invest. 2020 Aug;43(8):1171-1172
pubmed: 32488726
Growth Horm IGF Res. 2021 Feb;56:101363
pubmed: 33221709
Eur Thyroid J. 2018 Aug;7(4):167-186
pubmed: 30283735
J Endocrinol Invest. 2020 Dec;43(12):1819-1822
pubmed: 32329026
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
J Clin Endocrinol Metab. 2005 Mar;90(3):1897-9
pubmed: 15758064
Endocrinology. 2008 Jun;149(6):3062-6
pubmed: 18308843
N Engl J Med. 2020 Aug 6;383(6):590-592
pubmed: 32402155
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
P T. 2018 Feb;43(2):92-104
pubmed: 29386866
Ther Adv Musculoskelet Dis. 2019 Oct 05;11:1759720X19877994
pubmed: 31632472
BMC Med. 2020 Jul 15;18(1):220
pubmed: 32664957
JAMA. 2003 Jun 4;289(21):2801-9
pubmed: 12734147
Drugs R D. 2017 Mar;17(1):91-96
pubmed: 28105610
Anaesthesiol Intensive Ther. 2019;51(3):205-209
pubmed: 31418258
Rheumatology (Oxford). 2021 Jan 5;60(1):132-139
pubmed: 32596721
J Endocrinol Invest. 2012 Dec;35(11):1021-9
pubmed: 23143695
Sci Rep. 2016 Aug 03;6:30990
pubmed: 27484112
Arch Endocrinol Metab. 2021 Mar 19;:
pubmed: 33740339
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
J Med Virol. 2021 Mar;93(3):1361-1369
pubmed: 33090535
Immunol Lett. 2005 Feb 15;97(1):107-13
pubmed: 15626482
J Endocrinol Invest. 2021 Apr;44(4):765-771
pubmed: 32772324
Bone. 2017 Dec;105:11-17
pubmed: 28789921
Lancet Diabetes Endocrinol. 2020 Aug;8(8):654-656
pubmed: 32531251
J Clin Endocrinol Metab. 2020 Dec 1;105(12):
pubmed: 32738040
Med Hypotheses. 2020 Jul;140:109767
pubmed: 32353742
Eur J Clin Invest. 2004 May;34(5):382-4
pubmed: 15147338
J Clin Endocrinol Metab. 2020 Dec 1;105(12):
pubmed: 32929476
N Engl J Med. 2007 May 3;356(18):1809-22
pubmed: 17476007
Eur J Endocrinol. 2021 May;184(5):637-645
pubmed: 33635829
Respiration. 2021;100(2):116-126
pubmed: 33486496
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
J Clin Endocrinol Metab. 2015 Feb;100(2):407-16
pubmed: 25419882
Metabolism. 2020 Jul;108:154252
pubmed: 32353355
Open Forum Infect Dis. 2020 Mar 23;7(4):ofaa105
pubmed: 32284951
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):337-342
pubmed: 33493853
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Pharm Pharm Sci. 2020;23(1):75-85
pubmed: 32324533
JAMA Netw Open. 2021 May 3;4(5):e2111398
pubmed: 34032853
Endocr Metab Immune Disord Drug Targets. 2013 Mar;13(1):22-37
pubmed: 23369135
Endocrine. 2021 Jan;71(1):3-8
pubmed: 33179220
Endocrine. 2020 May;68(2):251-252
pubmed: 32346813
Folia Med (Plovdiv). 2020 Jun 30;62(2):223-229
pubmed: 32666762
J Clin Endocrinol Metab. 2008 May;93(5):1526-40
pubmed: 18334580
Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):e65-6
pubmed: 14672881
Reprod Toxicol. 2006 Aug;22(2):234-41
pubmed: 16704920
Res Rep Urol. 2020 Dec 01;12:615-621
pubmed: 33294423
Eur J Endocrinol. 2009 Feb;160(2):233-7
pubmed: 19011006
Compr Physiol. 2020 Sep 24;10(4):1277-1287
pubmed: 32969509
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
Metabolism. 2020 Jul;108:154262
pubmed: 32422233
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Nat Rev Endocrinol. 2020 Sep;16(9):467-468
pubmed: 32528045
J Clin Endocrinol Metab. 2008 Jun;93(6):2149-57
pubmed: 18381571
Front Immunol. 2019 Aug 27;10:2028
pubmed: 31507614
Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1140-4
pubmed: 16682487
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2003-2006
pubmed: 33091758
Eur J Endocrinol. 2017 Apr;176(4):471-480
pubmed: 28223394
ANZ J Surg. 2020 Jun;90(6):963-964
pubmed: 32336017
J Immunol. 2017 May 15;198(10):4046-4053
pubmed: 28373583
Front Endocrinol (Lausanne). 2020 Sep 11;11:554
pubmed: 33071957
Endocrinology. 2018 Sep 1;159(9):3306-3320
pubmed: 30032246
J Med Virol. 2020 Apr;92(4):433-440
pubmed: 31967321
Clin Endocrinol (Oxf). 1996 Feb;44(2):199-205
pubmed: 8849575
Fertil Steril. 2020 Jun;113(6):1135-1139
pubmed: 32482249
BMJ Case Rep. 2020 Aug 25;13(8):
pubmed: 32843467
J Med Virol. 2021 Feb;93(2):733-740
pubmed: 32716073
Pituitary. 2020 Aug;23(4):327-337
pubmed: 32556793
J Endocrinol Invest. 2020 Oct;43(10):1527-1528
pubmed: 32686042
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6485-90
pubmed: 24733925
Endocrine. 2020 Aug;69(2):237-240
pubmed: 32632722
Head Neck. 2020 Jun;42(6):1322-1324
pubmed: 32338793
Clin Microbiol Infect. 2021 Jan;27(1):36-46
pubmed: 33148440
Endocr Rev. 2019 Aug 1;40(4):1109-1151
pubmed: 30321335
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1429-1430
pubmed: 32755846
J Endocrinol Invest. 2021 Mar;44(3):635-636
pubmed: 32651894
Fertil Steril. 2020 Aug;114(2):233-238
pubmed: 32650948
N Engl J Med. 2020 Jun 18;382(25):e100
pubmed: 32302077
J Clin Endocrinol Metab. 2020 May 1;105(5):
pubmed: 32232480
J Endocrinol Invest. 2021 May;44(5):1085-1090
pubmed: 33025553
Ann Endocrinol (Paris). 2021 Jun;82(3-4):210-213
pubmed: 32473787
Am J Hematol. 2020 Jul;95(7):834-847
pubmed: 32282949
J Clin Pathol. 2021 Apr;74(4):261-263
pubmed: 32312717
Horm Behav. 2017 Feb;88:95-105
pubmed: 27956226
Case Rep Endocrinol. 2020 Sep 28;2020:8891539
pubmed: 33005461
J Interferon Cytokine Res. 2015 Oct;35(10):759-70
pubmed: 25978633
Eur J Endocrinol. 2010 Mar;162(3):597-602
pubmed: 19955259
Trials. 2020 Jun 26;21(1):573
pubmed: 32586399
Crit Rev Immunol. 2012;32(1):23-63
pubmed: 22428854
Andrology. 2021 Jan;9(1):53-64
pubmed: 32524732
J Med Virol. 2021 Jan;93(1):456-462
pubmed: 32621617
BMJ. 2020 Aug 25;370:m3223
pubmed: 32843355
Endocrine. 2015 Feb;48(1):25-35
pubmed: 24972804
Biochem Cell Biol. 2010 Aug;88(4):723-30
pubmed: 20651845
J Hum Hypertens. 2021 Apr;35(4):304-307
pubmed: 33483621
J Clin Endocrinol Metab. 2008 Apr;93(4):1351-8
pubmed: 18171701
J Endocrinol Invest. 2020 Aug;43(8):1141-1147
pubmed: 32335855
Nutrients. 2013 Jan 10;5(1):111-48
pubmed: 23306192
JBMR Plus. 2020 Aug 22;:
pubmed: 32904944
Endocr Metab Immune Disord Drug Targets. 2021;21(1):91-110
pubmed: 32433011
J Bone Miner Res. 2020 Jun;35(6):1009-1013
pubmed: 32406536
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
BMC Infect Dis. 2021 Feb 22;21(1):200
pubmed: 33618678
Drug Metab Dispos. 2007 Sep;35(9):1687-93
pubmed: 17576808
J Clin Orthop Trauma. 2020 Jul;11(Suppl 4):S431-S441
pubmed: 32774008
Endocrinology. 2017 Oct 1;158(10):3676-3683
pubmed: 28938449
Nutrients. 2020 Jul 15;12(7):
pubmed: 32679784
Urol Int. 2020;104(9-10):678-683
pubmed: 32781456
J Med Virol. 2021 Apr;93(4):2021-2028
pubmed: 32986248
N Engl J Med. 2020 Oct 29;383(18):1757-1766
pubmed: 32329974
Arch Pathol Lab Med. 2020 Oct 1;144(10):1159-1160
pubmed: 32579380
Med Hypotheses. 2004;63(5):855-62
pubmed: 15488660
Head Neck. 2020 Jun;42(6):1325-1328
pubmed: 32437031
Int J Mol Sci. 2018 Sep 08;19(9):
pubmed: 30205552
Thyroid. 2021 Jan;31(1):8-11
pubmed: 32600165
J Immunol. 2001 Nov 1;167(9):4974-80
pubmed: 11673504
Br J Anaesth. 2019 May;122(5):e73-e75
pubmed: 30916031
Nutrients. 2018 Apr 27;10(5):
pubmed: 29702603
Neuroendocrinology. 2010;92 Suppl 1:50-4
pubmed: 20829618
Climacteric. 2016 Aug;19(4):329-36
pubmed: 27327421
J Clin Endocrinol Metab. 2020 Oct 1;105(10):
pubmed: 32780854
Int J Mol Sci. 2017 Sep 12;18(9):
pubmed: 28895880
Eur J Endocrinol. 2018 May;178(5):447-458
pubmed: 29472378
J Clin Endocrinol Metab. 2007 Jul;92(7):2415-20
pubmed: 17440013
N Engl J Med. 2007 Jul 19;357(3):266-81
pubmed: 17634462
Ann Nucl Med. 2011 Dec;25(10):749-54
pubmed: 21971604
N Engl J Med. 2021 May 13;384(19):1866-1868
pubmed: 33761203
J Endocrinol Invest. 2018 Jul;41(7):849-876
pubmed: 29729004
Lancet Diabetes Endocrinol. 2016 Jul;4(7):611-29
pubmed: 27177728
Pituitary. 2018 Dec;21(6):631-641
pubmed: 29855779
Clin Endocrinol (Oxf). 2005 Aug;63(2):197-202
pubmed: 16060914
Open Forum Infect Dis. 2020 Oct 21;7(12):ofaa509
pubmed: 33403218
Crit Care. 2013 Jun 04;17(3):R106
pubmed: 23734769
Hum Reprod. 2021 Jun 18;36(7):2063-2064
pubmed: 33793791
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
PLoS One. 2019 Sep 24;14(9):e0222313
pubmed: 31550254
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:2324709621999954
pubmed: 33686899
Hormones (Athens). 2014 Jul-Sep;13(3):420-3
pubmed: 25079469
Diabetes Obes Metab. 2016 Dec;18(12):1274-1278
pubmed: 27392119
Eur J Endocrinol. 2020 Jul;183(1):G33-G39
pubmed: 32438340
J Endocrinol Invest. 2020 Aug;43(8):1169-1170
pubmed: 32488724
Clin Exp Immunol. 2019 Jan;195(1):52-63
pubmed: 30144040
Endocrinol Metab Clin North Am. 2010 Jun;39(2):365-79, table of contents
pubmed: 20511058
Endocrine. 2020 Jun;68(3):475-478
pubmed: 32533508
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
J Clin Endocrinol Metab. 2020 Feb 1;105(2):
pubmed: 31532828
Eur J Endocrinol. 2016 Aug;175(2):G1-G34
pubmed: 27390021
Med Drug Discov. 2020 Jun;6:100041
pubmed: 32352080
Lipids Health Dis. 2018 Oct 12;17(1):234
pubmed: 30309366
Endocr Metab Immune Disord Drug Targets. 2020;20(5):646-653
pubmed: 31742499
Endocrine. 2020 Nov;70(2):218-231
pubmed: 32743767
Eur J Endocrinol. 2020 Jul;183(1):G1-G7
pubmed: 32380475
Sci Rep. 2014 Nov 24;4:7176
pubmed: 25417801
J Endocrinol Invest. 2021 Jun;44(6):1335-1336
pubmed: 32915404
Med Hypotheses. 2020 Nov;144:110167
pubmed: 32795835
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
J Pharmacol Pharmacother. 2012 Apr;3(2):118-26
pubmed: 22629085
Lancet Diabetes Endocrinol. 2021 Apr;9(4):197-199
pubmed: 33617779
Auto Immun Highlights. 2020 Oct 6;11(1):15
pubmed: 33023649
Int J Environ Res Public Health. 2020 Sep 11;17(18):
pubmed: 32932954
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028
pubmed: 32286245
Endocrine. 2020 Jun;68(3):485-488
pubmed: 32500518
Eur J Endocrinol. 2020 Jul;183(1):G9-G15
pubmed: 32380474
Virology. 2018 Apr;517:3-8
pubmed: 29275820
Nat Med. 2020 Oct;26(10):1531-1533
pubmed: 32807936
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792
pubmed: 32687793
J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622
pubmed: 30907953
J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744
pubmed: 29562364
J Clin Endocrinol Metab. 2008 Mar;93(3):674-6
pubmed: 18326006
Adv Exp Med Biol. 2018;1067:239-253
pubmed: 29235066
Immunol Lett. 2020 Sep;225:31-32
pubmed: 32569607
Neuroendocrinology. 2010;92 Suppl 1:96-101
pubmed: 20829627
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
BMJ. 2020 Sep 1;370:m3320
pubmed: 32873575
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Nat Rev Immunol. 2020 Jul;20(7):442-447
pubmed: 32528136
Hormones (Athens). 2021 Mar;20(1):219-221
pubmed: 32676935
Hum Reprod. 2021 May 17;36(6):1520-1529
pubmed: 33522572
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 32310275
J Visc Surg. 2020 Jun;157(3S1):S43-S49
pubmed: 32448761
World J Mens Health. 2021 Jul;39(3):489-495
pubmed: 33663031
BMJ Open. 2021 Feb 25;11(2):e045524
pubmed: 33632754
Med Hypotheses. 2020 Dec;145:110329
pubmed: 33032171
Andrology. 2021 Jan;9(1):99-106
pubmed: 33150723
Mayo Clin Proc. 2020 Aug;95(8):1710-1714
pubmed: 32753145
Endocrinology. 2020 Sep 1;161(9):
pubmed: 32652001
J Endocrinol Invest. 2021 Feb;44(2):387-388
pubmed: 33025554
JAMA. 2021 Apr 6;325(13):1318-1320
pubmed: 33635317
Vaccine. 2021 Jan 22;39(4):667-677
pubmed: 33342635
Inflamm Regen. 2020 Feb 7;40:2
pubmed: 32047573
Lancet. 2020 Feb 15;395(10223):473-475
pubmed: 32043983
J Endocrinol Invest. 2020 Aug;43(8):1173-1174
pubmed: 32504458
J Endocrinol Invest. 2021 Mar 25;:
pubmed: 33765288
J Endocrinol Invest. 2020 Jul;43(7):1027-1031
pubmed: 32361826
J Am Coll Nutr. 2021 Feb;40(2):104-110
pubmed: 33434117
Eur J Endocrinol. 2019 Apr;180(4):P23-P54
pubmed: 30721133
Ann Intern Med. 2020 Oct 6;173(7):516-526
pubmed: 32716706
Aging Male. 2020 Dec;23(5):1493-1503
pubmed: 32883151
Biol Reprod. 2020 Jun 23;103(1):4-6
pubmed: 32297920
Neuroendocrinology. 2010;92 Suppl 1:55-9
pubmed: 20829619
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Eur J Endocrinol. 2020 Jul;183(1):G17-G23
pubmed: 32369770
Endocr Metab Immune Disord Drug Targets. 2021 Jan 01;:
pubmed: 33388025
J Clin Endocrinol Metab. 2013 Jun;98(6):2277-84
pubmed: 23533241
Rev Endocr Metab Disord. 2020 Nov 25;:
pubmed: 33241508
J Endocrinol Invest. 2021 May;44(5):1031-1040
pubmed: 33140379
J Med Virol. 2021 Feb;93(2):820-830
pubmed: 32691881
Front Endocrinol (Lausanne). 2020 Aug 18;11:565
pubmed: 33013686
J Biol Chem. 2010 Dec 10;285(50):38751-5
pubmed: 20974859
Horm Behav. 2012 Aug;62(3):263-71
pubmed: 22406114
Med Mal Infect. 2020 Jun;50(4):382-383
pubmed: 32259560
Endocrine. 2021 Feb;71(2):273-280
pubmed: 33415577
Lancet Respir Med. 2020 Dec;8(12):1159
pubmed: 33129420
Singapore Med J. 2020 Jul 16;:
pubmed: 32668831
Eur J Endocrinol. 2020 Aug;183(2):G57-G65
pubmed: 32396134
Andrology. 2021 Jan;9(1):88-98
pubmed: 32436355
Metabolism. 2019 Mar;92:193-205
pubmed: 30615949
BMC Med. 2020 Nov 25;18(1):369
pubmed: 33234138
Endocrine. 2020 Apr;68(1):2-5
pubmed: 32279224
J Endocrinol Invest. 2021 Feb 13;:
pubmed: 33583003
Pituitary. 2021 Apr;24(2):143-145
pubmed: 33564969
Endocr Connect. 2016 Sep;5(5):G9-G11
pubmed: 27935816
J Med Case Rep. 2020 Aug 24;14(1):134
pubmed: 32838801
J Investig Med. 2011 Aug;59(6):881-6
pubmed: 21527855
Nat Rev Immunol. 2008 Sep;8(9):737-44
pubmed: 18728636
J Clin Endocrinol Metab. 2012 Jun;97(6):2039-49
pubmed: 22466348
JAMA Netw Open. 2020 May 1;3(5):e208292
pubmed: 32379329
Nutrients. 2020 Apr 02;12(4):
pubmed: 32252338
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
BMJ. 2021 Feb 18;372:n494
pubmed: 33602668
Clin Endocrinol (Oxf). 2021 Apr 4;:
pubmed: 33813743
J Med Virol. 2020 Apr;92(4):448-454
pubmed: 31997390
Eur J Endocrinol. 2020 Oct;183(4):381-387
pubmed: 32698147
Trends Endocrinol Metab. 2020 Sep;31(9):655-669
pubmed: 32387195
Endocrine. 2021 Apr;72(1):12-19
pubmed: 33713312
Thyroid. 2001 Oct;11(10):929-34
pubmed: 11716039
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Front Physiol. 2021 Apr 14;12:651408
pubmed: 33935803
Sci Rep. 2021 Feb 12;11(1):3735
pubmed: 33580190
J Nucl Med. 2020 Sep;61(9):1278-1283
pubmed: 32709733
Endocr Relat Cancer. 2020 Nov;27(11):R407-R416
pubmed: 32810844
BMJ. 2017 Feb 15;356:i6583
pubmed: 28202713
Eur J Endocrinol. 2020 Jul;183(1):G25-G32
pubmed: 32379699
Endocr Rev. 2005 Aug;26(5):704-28
pubmed: 15632316
Endocr Connect. 2016 Sep;5(5):G7-G8
pubmed: 27935815
Aging (Albany NY). 2020 Jun 25;12(12):11287-11295
pubmed: 32589164
Front Med (Lausanne). 2021 Jan 07;7:590805
pubmed: 33490095
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
J Endocrinol Invest. 2020 Jul;43(7):1035-1036
pubmed: 32300975
Lancet Diabetes Endocrinol. 2020 Jul;8(7):570
pubmed: 32445630
N Engl J Med. 2001 Sep 13;345(11):841
pubmed: 11556316
BMJ Open. 2021 Jan 11;11(1):e044640
pubmed: 33431495
ISRN Endocrinol. 2014 Jan 22;2014:105456
pubmed: 24587915
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Ann Endocrinol (Paris). 2020 Oct;81(5):507-510
pubmed: 32950466
Endocrine. 2020 Dec;70(3):441-453
pubmed: 32779091
Front Immunol. 2015 Mar 18;6:100
pubmed: 25852682
J Clin Endocrinol Metab. 2006 Dec;91(12):4849-53
pubmed: 16968806
Med Hypotheses. 2020 Jul;140:109785
pubmed: 32344303
Cochrane Database Syst Rev. 2021 Mar 11;3:CD013879
pubmed: 33704775
J Clin Med Res. 2020 Oct;12(10):634-639
pubmed: 33029269
Life Sci Alliance. 2020 Jul 23;3(9):
pubmed: 32703818
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Nature. 2020 Jul;583(7816):437-440
pubmed: 32434211
Osteoporos Int. 2016 Aug;27(8):2395-410
pubmed: 26902094
Hematol Oncol Stem Cell Ther. 2020 Jul 30;:
pubmed: 32745466